TWST Twist Bioscience Corp

Price (delayed)

$123.87

Market cap

$6.06B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$2.65

Enterprise value

$5.69B

Twist Bioscience is a leading and rapidly growing synthetic biology and genomics company that has developed a disruptive DNA synthesis platform to industrialize the engineering of biology. The core of ...

Highlights
TWST's gross profit has surged by 185% year-on-year and by 18% since the previous quarter
TWST's revenue has soared by 72% YoY and by 12% from the previous quarter
Twist Bioscience's equity has surged by 132% YoY but it has decreased by 3.7% QoQ
TWST's quick ratio has surged by 78% year-on-year but it is down by 13% since the previous quarter

Key stats

What are the main financial stats of TWST
Market
Shares outstanding
48.89M
Market cap
$6.06B
Enterprise value
$5.69B
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
9.81
Price to sales (P/S)
53.39
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
50.34
Earnings
Revenue
$113M
EBIT
-$122.42M
EBITDA
-$114.83M
Free cash flow
-$115.25M
Per share
EPS
-$2.65
Free cash flow per share
-$2.37
Book value per share
$12.63
Revenue per share
$2.32
TBVPS
$13.88
Balance sheet
Total assets
$677.29M
Total liabilities
$63.11M
Debt
$31.93M
Equity
$614.18M
Working capital
$567.56M
Liquidity
Debt to equity
0.05
Current ratio
15.03
Quick ratio
14.41
Net debt/EBITDA
3.2
Margins
EBITDA margin
-101.6%
Gross margin
37%
Net margin
-109.2%
Operating margin
-108.8%
Efficiency
Return on assets
-22.6%
Return on equity
-25.5%
Return on invested capital
-43.6%
Return on capital employed
-19.2%
Return on sales
-108.3%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

TWST stock price

How has the Twist Bioscience stock price performed over time
Intraday
2.97%
1 week
4.02%
1 month
-5.71%
1 year
86.41%
YTD
-12.33%
QTD
-7.04%

Financial performance

How have Twist Bioscience's revenue and profit performed over time
Revenue
$113M
Gross profit
$41.77M
Operating income
-$122.96M
Net income
-$123.34M
Gross margin
37%
Net margin
-109.2%
TWST's gross profit has surged by 185% year-on-year and by 18% since the previous quarter
TWST's revenue has soared by 72% YoY and by 12% from the previous quarter
TWST's gross margin has surged by 66% year-on-year and by 6% since the previous quarter
Twist Bioscience's net margin has soared by 51% YoY and by 6% from the previous quarter

Growth

What is Twist Bioscience's growth rate over time

Valuation

What is Twist Bioscience stock price valuation
P/E
N/A
P/B
9.81
P/S
53.39
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
50.34
TWST's EPS is up by 40% year-on-year and by 2.6% since the previous quarter
Twist Bioscience's equity has surged by 132% YoY but it has decreased by 3.7% QoQ
TWST's P/B is 8% above its last 4 quarters average of 8.8
TWST's revenue has soared by 72% YoY and by 12% from the previous quarter
TWST's P/S is 18% above its last 4 quarters average of 44.1

Efficiency

How efficient is Twist Bioscience business performance
The return on equity has surged by 70% year-on-year and by 14% since the previous quarter
The ROA has soared by 65% YoY and by 12% from the previous quarter
Twist Bioscience's ROIC has soared by 60% YoY and by 6% from the previous quarter
TWST's return on sales has surged by 51% year-on-year and by 6% since the previous quarter

Dividends

What is TWST's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for TWST.

Financial health

How did Twist Bioscience financials performed over time
Twist Bioscience's total assets has surged by 109% YoY but it has decreased by 3.2% QoQ
TWST's quick ratio has surged by 78% year-on-year but it is down by 13% since the previous quarter
Twist Bioscience's debt is 95% less than its equity
Twist Bioscience's equity has surged by 132% YoY but it has decreased by 3.7% QoQ
Twist Bioscience's debt to equity has shrunk by 67% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.